CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Genovac Appoints Pete Leland as its VP of Production and Characterization

Life Sciences Review Life Sciences Review | Thursday, May 20, 2021
Tweet

Leland joins Genovac as Vice President of production and characterization.


FREMONT, CA: Pete Leland, a 20-year veteran of the biotechnology sector, joins Genovac Antibody Discovery, Fargo, N.D., as its Vice President of production and characterization.


Genovac is a contract research firm that discovers and develops antibodies for therapeutic, diagnostic, and research markets. The company's core technologies, genetic immunization, advanced hybridoma, and single B cell screening allow rapid antibody discovery against biopharma's most challenging targets. With the appointment of Leland, Genovac can now offer its clients robust production and characterization services.


Pete is an accomplished and recognized pioneer in biotechnology. Genovac is committed to being a one-stop-shop, offering antibody discovery, production, and characterization services. With Pete's expertise and experience, the company has hit the ground running in the United States. Genovac is lucky to have him at the head of a critical part of its scientific team. 


Leland heads the group that manufactures and tests antibodies, which Genovac customers use to develop drugs that help fight genetic and infectious diseases like Covid-19, cancer, and neurological disorders.


Genovac is doing cutting-edge work helping pharmaceutical and diagnostic firms across the world. It is very exciting to establish these technologies at the Fargo site while offering scientific career opportunities in the process. Before joining Genovac, Leland was a principal scientist for downstream process development at Catalent, Madison, Wis. Before that, and he was a manager at Patheon, a division of Thermos Fisher Scientific, and the senior manager of technical operations in the Madison, Wis., Protein Division of Fargo-based Aldevron.  Leland has a Bachelor of Arts in chemistry from St. Olaf College, Northfield, Minn., and a doctorate in biochemistry from the University of Wisconsin-Madison.


Genovac Antibody Discovery has completed more than 3,500 projects, delivering antibodies to clients in North America, Australia, Europe, and Asia developed into commercial drugs. Genovac has completed about 25 client and internal COVID-19 campaigns and has developed two antibodies that neutralize the U.K., Brazilian, and South African mutations.


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/genovac-appoints-pete-leland-as-its-vp-of-production-and-characterization-nwid-369.html